Content

Hepatoma Research 2024 Best Paper Awards

Published on: 14 Mar 2024 Viewed: 121

We are thrilled to unveil the recipients of the "Hepatoma Research 2024 Best Paper Awards" for outstanding articles published in Hepatoma Research from January 1, 2022, to December 31, 2022. The selection process for these awards was meticulously carried out by the esteemed Selection Committee of Hepatoma Research, under the leadership of our Editor-in-Chief Prof. Guangwen Cao and Executive Chief Editor Prof. Giuliano Ramadori.

Out of 41 publications throughout 2022, the Selection Committee has identified five papers as exemplary contributions to the field. These papers have been honored with one First Prize, two Second Prizes, and two Third Prizes.

First Prize:

1. Histopathology of hepatocellular carcinoma-when and what

PDF: https://f.oaecdn.com/xmlpdf/b2c03eca-0ed1-4345-9b0f-2041d9c92d36/4511_down.pdf?v=19

Cite This Article: Gisder DM, Tannapfel A, Tischoff I. Histopathology of hepatocellular carcinoma - when and what. Hepatoma Res 2022;8:4. http://dx.doi.org/10.20517/2394-5079.2021.131

Second Prize:

1. Hepatocellular carcinoma surveillance: Current practice and future directions

PDF: https://f.oaecdn.com/xmlpdf/f41fd0a0-3642-4d8b-95c5-432d03ae47cf/4614_down.pdf?v=38

Cite This Article: Ahn JC, Lee YT, Agopian VG, Zhu Y, You S, Tseng HR, Yang JD. Hepatocellular carcinoma surveillance: current practice and future directions. Hepatoma Res 2022;8:10. http://dx.doi.org/10.20517/2394-5079.2021.131

2. Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

PDF: https://f.oaecdn.com/xmlpdf/70608cbc-7f9e-494a-b87e-152c1a1b5a7d/4557_down.pdf?v=66

Cite This Article: Anugwom CM, Leventhal TM, Debes JD. Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant. Hepatoma Res 2022;8:7. http://dx.doi.org/10.20517/2394-5079.2021.123

Third Prize:

1. Role of Locoregional Therapies in the Management of Patients with Hepatocellular Carcinoma

PDF: https://f.oaecdn.com/xmlpdf/e53e1163-347b-4b76-94c5-e6e70ad6cf5d/4598_down.pdf?v=88

Cite This Article: Kung JWC, Ng KKC. Role of locoregional therapies in the management of patients with hepatocellular carcinoma. Hepatoma Res 2022;8:17. http://dx.doi.org/10.20517/2394-5079.2021.138

2. Robotic donor hepatectomy: a niche advancement or the way forward? A perspective from the world's largest center

PDF: https://f.oaecdn.com/xmlpdf/5375ed35-ea00-4f1d-8ead-ec6cb202c8a6/4497_down.pdf?v=44

Cite This Article: Sturdevant M, Zidan A, Broering D. Robotic donor hepatectomy: a niche advancement or the way forward? A perspective from the world's largest center. Hepatoma Res 2022;8:1. http://dx.doi.org/10.20517/2394-5079.2021.111

The Editorial Office of Hepatoma Research extends its heartfelt gratitude and congratulations to the recipients for their exceptional research published in the journal. We take immense pride in showcasing such groundbreaking contributions.

Furthermore, we wholeheartedly welcome international scientists to submit their high-quality papers to Hepatoma Research. We eagerly anticipate the opportunity to disseminate more innovative ideas and cutting-edge research among our esteemed peers.

Editor: Eric Zhang
Language Editor: Catherine Yang
Production Editor: Yan Zhang
Respectfully Submitted by the Editorial Office of Hepatoma Research

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/